Hit to Lead Evaluation of 1,2,3-Triazolo[4,5-B]Pyridines as Pim Kinase Inhibitors.
Pastor, J., Oyarzabal, J., Saluste, G., Alvarez, R.M., Rivero, V., Ramos, F., Cendon, E., Blanco-Aparicio, C., Ajenjo, N., Cebria, A., Albarran, M.I., Cebrian, D., Corrionero, A., Fominaya, J., Montoya, G., Mazzorana, M.(2012) Bioorg Med Chem Lett 22: 1591
- PubMed: 22266039 
- DOI: https://doi.org/10.1016/j.bmcl.2011.12.130
- Primary Citation of Related Structures:  
4A7C - PubMed Abstract: 
PIM kinases have become targets of interest due to their association with biochemical mechanisms affecting survival, proliferation and cytokine production. 1,2,3-Triazolo[4,5-b]pyridines were identified as PIM inhibitors applying a scaffold hopping approach. Initial exploration around this scaffold and X-ray crystallographic data are hereby described.
Organizational Affiliation: 
Experimental Therapeutics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. [email protected]